First recognized as regulators of development in worms and fruitflies, microRNAs are
emerging as pivotal modulators of mammalian cardiovascular development and disease …

Obesity-driven chronic inflammation and impaired fibrinolysis appear to be major effector
mechanisms of thrombosis in obesity. The proinflammatory and hypofibrinolytic effects of …

Abstract Background and Objective Recent emerging evidence has shown that microRNA
(miRNAs) is involved in several epigenetic processes linked with periodontitis, increased …

It is widely accepted that diabetes mellitus (DM) impairs endothelial nitric oxide synthase
activity as well as enhances the production of reactive oxygen species, thus resulting in …

For decades, mesenchymal stem (MSCs) cells have been used for cardiovascular diseases
as regenerative therapy. This review is an attempt to summarize the types of MSCs involved …

After the onset of ischemia, cardiac or skeletal muscle undergoes a continuum of molecular,
cellular, and extracellular responses that determine the function and the remodeling of the …

Global epidemiological studies show that chronic non-communicable diseases such as
atherosclerosis and metabolic disorders represent the leading cause of premature mortality …

MicroRNAs (miRNAs) are important regulators of adaptive and maladaptive responses in
cardiovascular diseases and hence are considered to be potential therapeutical targets …

Diabetes mellitus (DM) adversely affects the number and function of circulating endothelial
progenitor cells (EPCs). Consequently, there is also a reduction in the repair mechanism of …

MicroRNA-21 (miR-21) expression is activated in multiple types of cancers, such as breast,
liver, brain, prostate, myometrial cancers but also in cardiovascular disease. MiR-21 …